Anders Malm Appointed Managing Director at Ecron Acunova A/S
COPENHAGEN, Denmark--(BUSINESS WIRE)--Jun 1, 2012-- D A Prasanna, Founder and Chairman of Ecron Acunova group (EA), is pleased to announce the appointment of Anders Malm as Managing Director for the Nordic countries. Mr. Malm will be accountable for all operational and business development aspects of the Nordic operations. He will report to Dr. Wiedey, CEO Europe.
With more than 20 years global experience in managing business, Mr.
Malm brings valuable new insights. He has been active in CRO businesses over the last ten years, and his last position was CEO for Pharmatech Oncology in Denver, USA from 2005 to 2012. Mr. Malm has a science background with a masters degree from Cornell University, USA and a MBA from Sweden.
Mr. Prasanna, Chairman and Founder of EA said: "Mr. Malm unifies extensive professional experience in clinical research and in-depth knowledge of the Nordic and US geographies. With his worldwide contacts and inter personal skills Mr. Malm will support EA to grow to its next level of achievements." On his appointment, Mr. Malm said "I look forward to come home to work in the Nordic region again. Backed by professional investigator sites which are eager to support us in clinical development and EA's highly qualified, committed and enthusiastic team, EA has an amazing potential and outstanding opportunities ahead to serve clients in the pharmaceutical, biotech, device and diagnostics industries." EA is an expert CRO with 25 years of track record. It offers full-service clinical research including clinical operations, data management, biostatistics, pharmacovigilance, PK/PD services and central lab to pharma, biotech, medical device, nutrition and diagnostic companies. EA covers 19 Western & Eastern European countries as well as 9 South Asian & South East Asian countries. EA operates each region as a priority market with European HQ in Frankfurt, Asian HQ in Bangalore, and US HQ at Princeton, NJ. With a team of 380 professionals including 80 MDs, PhDs and alike, EA is reputed to accelerate pharma time to market cost effectively.
For further details please visit www.ecronacunova.com or contact Mr.
Malm, who will operate from the offices in Hørsholm, Denmark and Stockholm, Sweden.
CONTACT: Ecron Acunova A/S India D A Prasanna Tel: +91 80 66 91 57 00 firstname.lastname@example.org or Denmark Anders Malm Tel: +45 45 16 88 00 email@example.com KEYWORD: EUROPE DENMARK INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL SOURCE: Ecron Acunova A/S Copyright Business Wire 2012 PUB: 06/01/2012 02:43 AM/DISC: 06/01/2012 02:43 AM http://www.businesswire.com/news/home/20120531005033/